Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07495-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850172966734659584 |
|---|---|
| author | Yang Li Zhichao Xi Xiaoqiong Chen Shuangfan Cai Chen Liang Zhen Wang Yingyi Li Hongsheng Tan Yuanzhi Lao Hongxi Xu |
| author_facet | Yang Li Zhichao Xi Xiaoqiong Chen Shuangfan Cai Chen Liang Zhen Wang Yingyi Li Hongsheng Tan Yuanzhi Lao Hongxi Xu |
| author_sort | Yang Li |
| collection | DOAJ |
| format | Article |
| id | doaj-art-3949f5b57e5d4d3f81510a8334730c19 |
| institution | OA Journals |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-3949f5b57e5d4d3f81510a8334730c192025-08-20T02:19:57ZengNature Publishing GroupCell Death and Disease2041-48892025-04-011611610.1038/s41419-025-07495-2Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathwaysYang Li0Zhichao Xi1Xiaoqiong Chen2Shuangfan Cai3Chen Liang4Zhen Wang5Yingyi Li6Hongsheng Tan7Yuanzhi Lao8Hongxi Xu9School of Pharmacy, Shanghai University of Traditional Chinese MedicineSchool of Pharmacy, Shanghai University of Traditional Chinese MedicineSchool of Pharmacy, Shanghai University of Traditional Chinese MedicineSchool of Pharmacy, Shanghai University of Traditional Chinese MedicineCancer Research Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan UniversityCancer Research Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan UniversityCancer Research Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan UniversitySchool of Pharmacy, Shanghai University of Traditional Chinese MedicineSchool of Pharmacy, Shanghai University of Traditional Chinese MedicineSchool of Pharmacy, Shanghai University of Traditional Chinese Medicinehttps://doi.org/10.1038/s41419-025-07495-2 |
| spellingShingle | Yang Li Zhichao Xi Xiaoqiong Chen Shuangfan Cai Chen Liang Zhen Wang Yingyi Li Hongsheng Tan Yuanzhi Lao Hongxi Xu Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways Cell Death and Disease |
| title | Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways |
| title_full | Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways |
| title_fullStr | Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways |
| title_full_unstemmed | Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways |
| title_short | Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways |
| title_sort | correction to natural compound oblongifolin c confers gemcitabine resistance in pancreatic cancer by downregulating src mapk erk pathways |
| url | https://doi.org/10.1038/s41419-025-07495-2 |
| work_keys_str_mv | AT yangli correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT zhichaoxi correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT xiaoqiongchen correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT shuangfancai correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT chenliang correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT zhenwang correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT yingyili correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT hongshengtan correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT yuanzhilao correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways AT hongxixu correctiontonaturalcompoundoblongifolincconfersgemcitabineresistanceinpancreaticcancerbydownregulatingsrcmapkerkpathways |